Purple Biotech Ltd. (PPBT) stock declines during after-hour. Here’s what you should know?
Purple Biotech Ltd. (NASDAQ; PPBT) stock declined by 11.76% at last close whereas the PPBT stock price plunge during after-hour by 9.78%. Purple Biotech, a clinical-stage firm focused on combating tumor immune evasion and medication resistance to produce first-in-class medicines. NT219 and CM24 are part of PPBT’s oncology pipeline. What is happening? PPBT has recently […]
Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial
Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71. CM24 Trial Commences Patient Dosing […]
